Antisense delivery using protamine–oligonucleotide particles

By Junghans M.   Kreuter J.   Zimmer A.  

Nucleic Acids Research, Vol. 28, Iss. 10, 2000-05 ,pp. : 45-45

Oxford University Press

Access to resources Recommend Favorite

Antisense oligonucleotide treatments for psoriasis

By White PJ   Atley LM   Wraight CJ  

Expert Opinion on Biological Therapy, Vol. 4, Iss. 1, 2004-01 ,pp. : 75-81

Informa Healthcare

Access to resources Recommend Favorite

Selecting optimal oligonucleotide composition for maximal antisense effect following streptolysin O‐mediated delivery into human leukaemia cells

By Giles R. V.  

Nucleic Acids Research, Vol. 26, Iss. 7, 1998-04 ,pp. : 1567-1575

Oxford University Press

Access to resources Recommend Favorite

RASONs: a novel antisense oligonucleotide therapeutic approach for asthma

By Tang Lei   Sandrasagra Anthony   Teng Kelly   Nyce Jonathan W   Li Yukui   Mannion James C   Leonard Sherry A  

Expert Opinion on Biological Therapy, Vol. 1, Iss. 6, 2001-11 ,pp. : 979-983

Informa Healthcare

Access to resources Recommend Favorite

Discovery and Analysis of Antisense Oligonucleotide Activity in Cell Culture

By Baker B.F.   Condon T.P.   Koller E.   McKay R.A.   Siwkowski A.M.   Vickers T.A.   Monia B.P.  

Methods, Vol. 23, Iss. 2, 2001-02 ,pp. : 191-198

Academic Press

Access to resources Recommend Favorite